Health
globalreutersMay 13, 20241 Mins read
Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business
globalreutersMay 13, 20241 Mins read 
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.
Related Articles
Top Hospitals for Pacemaker Implantation Surgery in India: What you need to know?
Pacemaker implantation is a life-saving procedure for people with irregular heart rhythms....
Links
When is a public health problem a crisis? LA has the worst...
Remembering Thomas E. Kurtz
By MIKE MAGEE This has been a challenging week for me, but...
Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors
Seen Health emerged from stealth on Monday. The company builds on the...
Leave a comment